Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury

Gilbert Aaron Lee*, Teng Nan Lin, Cheng Yu Chen, Shin Yi Mau, Wan Zhen Huang, Yu Chieh Kao, Ruo yu Ma, Nan Shih Liao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Abstract

Acute ischemic stroke is followed by a complex interplay between the brain and the immune system in which ischemia-reperfusion leads to a detrimental inflammatory response that causes brain injury. In the brain, IL-15 is expressed by astrocytes, neurons and microglia. Previous study showed that ischemia-reperfusion induces expression of IL-15 by astrocytes. Transgenic over-expression of IL-15 in astrocytes aggravates ischemia-reperfusion brain damage by increasing the levels and promoting the effector functions of CD8 + T and NK cells. Treatment of neonatal rats with IL-15 neutralizing antibody before hypoxia-ischemia induction reduces the infarct volume. However, as stroke-induced inflammatory responses differ between neonate and adult brain, the effects of IL-15 blockade on the injury and immune response arising from stroke in adult animals has remained unclear. In this study, we examined the effect of post-ischemia/reperfusion IL-15 blockade on the pathophysiology of cerebral ischemia-reperfusion in adult mice. Using a cerebral ischemia-reperfusion model, we compared infarct size and the infiltrating immune cells in the brain of wild type (WT) mice and Il15 −/− mice lacking NK and memory CD8 + T cells. We also evaluated the effects of IL-15 neutralizing antibody treatment on brain infarct volume, motor function, and the status of brain-infiltrating immune cells in WT mice. Il15 −/− mice show a smaller infarct volume and lower numbers of activated brain-infiltrating NK, CD8 + T, and CD4 + T cells compared to WT mice after cerebral ischemia-reperfusion. Post-ischemia/reperfusion IL-15 blockade reduces infarct size and improves motor and locomotor activity. Furthermore, IL-15 blockade reduces the effector function of NK, CD8 + T, and CD4 + T cells in the ischemia-reperfusion brain of WT mice. Ablation of IL-15 responses after cerebral ischemia-reperfusion ameliorates brain injury in adult mice. Therefore, targeting IL-15 is a potential effective therapy for ischemic stroke.

Original languageEnglish
Pages (from-to)562-570
Number of pages9
JournalBrain, Behavior, and Immunity
Volume73
DOIs
StatePublished - Oct 2018

Keywords

  • Cerebral ischemia-reperfusion
  • IL-15
  • IL-15 antibody
  • Immune response

Fingerprint

Dive into the research topics of 'Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury'. Together they form a unique fingerprint.

Cite this